
Jean F. Voltaire
Examiner (ID: 18083, Phone: (571)272-3953 , Office: P/2466 )
| Most Active Art Unit | 2466 |
| Art Unit(s) | 2466, 2417 |
| Total Applications | 487 |
| Issued Applications | 381 |
| Pending Applications | 55 |
| Abandoned Applications | 68 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7033193
[patent_doc_number] => 20050031702
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Application of arsenic as a cancer and heart disease prevention agent'
[patent_app_type] => utility
[patent_app_number] => 10/634869
[patent_app_country] => US
[patent_app_date] => 2003-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3169
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20050031702.pdf
[firstpage_image] =>[orig_patent_app_number] => 10634869
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/634869 | Application of arsenic as a cancer and heart disease prevention agent | Aug 5, 2003 | Abandoned |
Array
(
[id] => 121887
[patent_doc_number] => 07709529
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-04
[patent_title] => 'Treatment of cancer with glutamine'
[patent_app_type] => utility
[patent_app_number] => 10/633402
[patent_app_country] => US
[patent_app_date] => 2003-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 33
[patent_no_of_words] => 24545
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/709/07709529.pdf
[firstpage_image] =>[orig_patent_app_number] => 10633402
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/633402 | Treatment of cancer with glutamine | Jul 31, 2003 | Issued |
Array
(
[id] => 7468517
[patent_doc_number] => 20040096436
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-20
[patent_title] => 'Methods for inhibiting protein kinases in cancer cells'
[patent_app_type] => new
[patent_app_number] => 10/632592
[patent_app_country] => US
[patent_app_date] => 2003-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 19595
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20040096436.pdf
[firstpage_image] =>[orig_patent_app_number] => 10632592
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/632592 | Methods for inhibiting protein kinases in cancer cells | Jul 31, 2003 | Abandoned |
Array
(
[id] => 7324986
[patent_doc_number] => 20040138094
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-15
[patent_title] => 'Treatment regimes'
[patent_app_type] => new
[patent_app_number] => 10/470886
[patent_app_country] => US
[patent_app_date] => 2003-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4017
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0138/20040138094.pdf
[firstpage_image] =>[orig_patent_app_number] => 10470886
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/470886 | Treatment regimes | Jul 30, 2003 | Abandoned |
Array
(
[id] => 602198
[patent_doc_number] => 07431959
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2008-10-07
[patent_title] => 'Method and system for irradiation of a drug eluting implantable medical device'
[patent_app_type] => utility
[patent_app_number] => 10/631116
[patent_app_country] => US
[patent_app_date] => 2003-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 12
[patent_no_of_words] => 10792
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/431/07431959.pdf
[firstpage_image] =>[orig_patent_app_number] => 10631116
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/631116 | Method and system for irradiation of a drug eluting implantable medical device | Jul 30, 2003 | Issued |
Array
(
[id] => 7314732
[patent_doc_number] => 20040034101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-19
[patent_title] => 'Treatment and prevention of depression secondary to pain (DSP)'
[patent_app_type] => new
[patent_app_number] => 10/628141
[patent_app_country] => US
[patent_app_date] => 2003-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8079
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20040034101.pdf
[firstpage_image] =>[orig_patent_app_number] => 10628141
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/628141 | Treatment and prevention of depression secondary to pain (DSP) | Jul 23, 2003 | Abandoned |
Array
(
[id] => 800421
[patent_doc_number] => 07425565
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-09-16
[patent_title] => 'Use of benzothiopenes to treat and prevent prostate cancer'
[patent_app_type] => utility
[patent_app_number] => 10/625152
[patent_app_country] => US
[patent_app_date] => 2003-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 16
[patent_no_of_words] => 6965
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/425/07425565.pdf
[firstpage_image] =>[orig_patent_app_number] => 10625152
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/625152 | Use of benzothiopenes to treat and prevent prostate cancer | Jul 22, 2003 | Issued |
Array
(
[id] => 5678420
[patent_doc_number] => 20060183776
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2006-08-17
[patent_title] => 'Liquid dosage formulations of donepezil'
[patent_app_type] => utility
[patent_app_number] => 10/623577
[patent_app_country] => US
[patent_app_date] => 2003-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9543
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0183/20060183776.pdf
[firstpage_image] =>[orig_patent_app_number] => 10623577
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/623577 | Liquid dosage formulations of donepezil | Jul 21, 2003 | Abandoned |
Array
(
[id] => 5678420
[patent_doc_number] => 20060183776
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2006-08-17
[patent_title] => 'Liquid dosage formulations of donepezil'
[patent_app_type] => utility
[patent_app_number] => 10/623577
[patent_app_country] => US
[patent_app_date] => 2003-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9543
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0183/20060183776.pdf
[firstpage_image] =>[orig_patent_app_number] => 10623577
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/623577 | Liquid dosage formulations of donepezil | Jul 21, 2003 | Abandoned |
Array
(
[id] => 7468701
[patent_doc_number] => 20040167146
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-26
[patent_title] => 'Method of treatment'
[patent_app_type] => new
[patent_app_number] => 10/622492
[patent_app_country] => US
[patent_app_date] => 2003-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3008
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20040167146.pdf
[firstpage_image] =>[orig_patent_app_number] => 10622492
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/622492 | Method of treatment | Jul 20, 2003 | Abandoned |
Array
(
[id] => 7267857
[patent_doc_number] => 20040056375
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-25
[patent_title] => 'Method and apparatus for making miniature tablets'
[patent_app_type] => new
[patent_app_number] => 10/624777
[patent_app_country] => US
[patent_app_date] => 2003-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 5463
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0056/20040056375.pdf
[firstpage_image] =>[orig_patent_app_number] => 10624777
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/624777 | Method and apparatus for making miniature tablets | Jul 20, 2003 | Abandoned |
Array
(
[id] => 7400897
[patent_doc_number] => 20040018987
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-29
[patent_title] => 'Redox therapy for tumors'
[patent_app_type] => new
[patent_app_number] => 10/621326
[patent_app_country] => US
[patent_app_date] => 2003-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14188
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20040018987.pdf
[firstpage_image] =>[orig_patent_app_number] => 10621326
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/621326 | Redox therapy for tumors | Jul 17, 2003 | Issued |
Array
(
[id] => 4524618
[patent_doc_number] => 07951840
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-05-31
[patent_title] => 'Zinc salt compositions for the prevention of dermal and mucosal irritation'
[patent_app_type] => utility
[patent_app_number] => 10/622272
[patent_app_country] => US
[patent_app_date] => 2003-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14913
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/951/07951840.pdf
[firstpage_image] =>[orig_patent_app_number] => 10622272
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/622272 | Zinc salt compositions for the prevention of dermal and mucosal irritation | Jul 16, 2003 | Issued |
Array
(
[id] => 6825561
[patent_doc_number] => 20030236183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-25
[patent_title] => 'Oral formulation'
[patent_app_type] => new
[patent_app_number] => 10/620178
[patent_app_country] => US
[patent_app_date] => 2003-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7960
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0236/20030236183.pdf
[firstpage_image] =>[orig_patent_app_number] => 10620178
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/620178 | Oral formulation | Jul 14, 2003 | Abandoned |
Array
(
[id] => 7460721
[patent_doc_number] => 20040052847
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-18
[patent_title] => 'Oral dosage forms of water insoluble drugs and methods of making the same'
[patent_app_type] => new
[patent_app_number] => 10/617350
[patent_app_country] => US
[patent_app_date] => 2003-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8367
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20040052847.pdf
[firstpage_image] =>[orig_patent_app_number] => 10617350
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/617350 | Oral dosage forms of water insoluble drugs and methods of making the same | Jul 10, 2003 | Issued |
Array
(
[id] => 7674596
[patent_doc_number] => 20040127522
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-01
[patent_title] => 'Methods of treating cancer with HDAC inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/616649
[patent_app_country] => US
[patent_app_date] => 2003-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 19311
[patent_no_of_claims] => 270
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20040127522.pdf
[firstpage_image] =>[orig_patent_app_number] => 10616649
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/616649 | Methods of treating cancer with HDAC inhibitors | Jul 8, 2003 | Issued |
Array
(
[id] => 7473957
[patent_doc_number] => 20040097408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-20
[patent_title] => 'Compounds regulating cell proliferation and differentiation'
[patent_app_type] => new
[patent_app_number] => 10/613762
[patent_app_country] => US
[patent_app_date] => 2003-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 28714
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0097/20040097408.pdf
[firstpage_image] =>[orig_patent_app_number] => 10613762
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/613762 | Compounds regulating cell proliferation and differentiation | Jul 2, 2003 | Abandoned |
Array
(
[id] => 7254995
[patent_doc_number] => 20050075315
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-07
[patent_title] => 'Antitumor agent'
[patent_app_type] => utility
[patent_app_number] => 10/611902
[patent_app_country] => US
[patent_app_date] => 2003-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 3936
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0075/20050075315.pdf
[firstpage_image] =>[orig_patent_app_number] => 10611902
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/611902 | Antitumor agent | Jul 2, 2003 | Abandoned |
Array
(
[id] => 7206639
[patent_doc_number] => 20040087513
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-06
[patent_title] => 'New drug combinations based on sodium channel blockers and magnesium salts'
[patent_app_type] => new
[patent_app_number] => 10/612107
[patent_app_country] => US
[patent_app_date] => 2003-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5712
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20040087513.pdf
[firstpage_image] =>[orig_patent_app_number] => 10612107
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/612107 | New drug combinations based on sodium channel blockers and magnesium salts | Jul 1, 2003 | Abandoned |
Array
(
[id] => 7404788
[patent_doc_number] => 20040024015
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-05
[patent_title] => 'Tumor radiosensitization and /or chemopotentiation using isocoumarin derivatives'
[patent_app_type] => new
[patent_app_number] => 10/610022
[patent_app_country] => US
[patent_app_date] => 2003-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9700
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0024/20040024015.pdf
[firstpage_image] =>[orig_patent_app_number] => 10610022
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/610022 | Tumor radiosensitization and /or chemopotentiation using isocoumarin derivatives | Jun 29, 2003 | Abandoned |